Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
about
Meat and Nicotinamide: A Causal Role in Human Evolution, History, and Demographics.Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?Glycation potentiates neurodegeneration in models of Huntington's disease.Progesterone Alters Kynurenine Pathway Activation in IFN-γ-Activated Macrophages - Relevance for Neuroinflammatory Diseases.Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.The Kollias legacy: Skin autofluorescence and beyond.Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.Identification of an evolutionary conserved structural loop that is required for the enzymatic and biological function of tryptophan 2,3-dioxygenase.Alcohol-Enhanced Cu-Mediated Radiofluorination.Antidiabetic Drug Metformin Protects Neuronal Cells against Quinolinic Acid-Induced Excitotoxicity by Decreasing Intracellular Calcium.Stepwise O-Atom Transfer in Heme-Based Tryptophan Dioxygenase: Role of Substrate Ammonium in Epoxide Ring Opening.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.Effects of N-acetyl-L-cysteine on lifespan, locomotor activity and stress-resistance of 3 species with different lifespans
P2860
Q33637828-4BC644AF-0094-4E03-9541-5C700CD8EC26Q33642585-C6C88731-233B-4CB6-99AE-86DBF23ABEEEQ37421997-FA09326B-C522-49B2-AE2A-3F027A62A3F5Q37489173-DDBB5A38-65ED-4346-84B6-CA68FADA826CQ37602166-DAB653E4-A93D-4164-AAC9-520DB4CF0ED0Q38672291-AFC54AA6-E4AE-4890-8838-8B1BD435453AQ38719357-2A9D98D0-7457-41BD-A7E7-B9A695CDB3FFQ38749757-6C969BE3-5B72-4E28-8E22-DDC5537BDC55Q39185463-A626EDEA-5C61-4BAC-AC1E-E4BF28C05059Q39485713-E3F409C4-9E14-4852-9605-0823B8FB4C55Q48164114-A08F68E3-47D1-4282-A97A-4CDAFDF9F9B6Q49302276-CA07D7EF-F5DD-4C5E-BABA-12D3D9CEF1D8Q53839714-D7E3D8D3-C946-4CFC-A89B-0430BDC014CDQ55381445-95E694E7-84A2-4FCC-954C-D241881AC130Q58709318-3D897B73-7324-4AD2-9ACF-D308A8381B81
P2860
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@ast
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@en
type
label
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@ast
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@en
prefLabel
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@ast
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@en
P2093
P2860
P356
P1476
Tryptophan-2,3-dioxygenase (TD ...... kynurenine pathway metabolites
@en
P2093
Charalambos P Kyriacou
Edward W Green
Flaviano Giorgini
Francesca M Notarangelo
Gareth G L Moore
Jasper G Estranero
Korrapati V Sathyasaikumar
Robert Schwarcz
Shama Sograte Idrissi
P2860
P304
P356
10.1073/PNAS.1604453113
P407
P50
P577
2016-04-25T00:00:00Z